4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults

Open Forum Infect Dis · 2020 · PMC7776102

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

No meaningful differences were seen between age groups in terms of humoral (except a slight trend for stronger responses in the 18–49 YOA RT and HM patients compared to their corresponding ≥ 50 YOA group) and gE-specific CD4 T-cell responses in any of the IC populations.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.